安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Prostate Cancer Diagnostic Imaging Agent | PYLARIFY®
PYLARIFY (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy
- Piflufolastat (18F) - Wikipedia
Piflufolastat (18F), sold under the brand name Pylarify among others, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging [1][4][5] It is given by intravenous injection [1][4] The most common adverse reactions include headache, altered taste, and fatigue [4]
- FDA approves second PSMA-targeted PET imaging drug for men with . . .
FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer
- What is PYLARIFY® How Does it Work?
PYLARIFY® is an imaging agent for PET CT scans that uses a unique combination of a PSMA-targeted small molecule and the radioactive tracer 18 F to help your doctor make more informed treatment choices based on clear images PYLARIFY® may help detect metastases even when PSA levels are low
- Pylarify: Package Insert Prescribing Information MOA
Pylarify package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
- New PSMA-Targeted Imaging Agent | PYLARIFY TruVu™
The now-approved PYLARIFY TruVu™ (piflufolastat F 18) is a newly formulated PSMA-targeted PET imaging agent in prostate cancer See safety and full PI
- Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18 . . .
PYLARIFY TruVu™ (piflufolastat F 18) Injection, a new formulation of Lantheus' widely-used U S market-leading PSMA PET imaging agent that combines the diagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for larger batches and greater patient availability
- label - Food and Drug Administration
PYLARIFY binds to prostate-specific membrane antigen (PSMA) Based on the intensity of the signals, PET images obtained using PYLARIFY indicate the presence of PSMA in tissues
|
|
|